Provided by Tiger Trade Technology Pte. Ltd.

Agree

74.41
+0.01000.01%
Post-market: 74.410.00000.00%19:13 EDT
Volume:945.68K
Turnover:70.55M
Market Cap:8.93B
PE:42.04
High:75.33
Open:74.40
Low:74.03
Close:74.40
52wk High:82.08
52wk Low:68.98
Shares:120.03M
Float Shares:108.37M
Volume Ratio:0.57
T/O Rate:0.87%
Dividend:3.08
Dividend Rate:4.14%
EPS(TTM):1.77
EPS(LYR):1.77
ROE:3.48%
ROA:2.37%
PB:1.47
PE(LYR):42.04

Loading ...

Whitehawk’s First-in-Human PTK7 ADC Trial Moves Ahead: What Investors Should Know

TIPRANKS
·
Yesterday

Fed Officials Agree Inflation is Stuck. They Don't Agree on How to Respond. -- Barrons.com

Dow Jones
·
Mar 27

A Look At Zymeworks (ZYME) Valuation As New AACR ADC Data Advances Its Cancer Pipeline

Simply Wall St.
·
Mar 27

$27 XRP Price? Standard Chartered and Analyst Agree: ‘Path Might Shift, But the Targets Always Remain’

TIPRANKS
·
Mar 27

Biocytogen Partner NEOK Bio Wins FDA IND Clearance for Bispecific-Based ADC NEOK002

TIPRANKS
·
Mar 26

BIOCYTOGEN-B Partner NEOK Bio Secures FDA IND Clearance for Bispecific ADC NEOK002, Reaching Critical Collaboration Milestone

Stock News
·
Mar 26

Sichuan Kelun-Biotech’s SKB103 IND Adds ADC Momentum And Valuation Upside

Simply Wall St.
·
Mar 26

Lepu Biopharma Swings to Profit as ADC Pipeline and Licensing Deals Gain Traction

TIPRANKS
·
Mar 25

Chiba Bank, Chiba Kogyo Bank Agree To Form Holding Company

MT Newswires Live
·
Mar 25

Horizon Oil, Mereenie JV Partners Agree to Extend Deadline for Gas Sales Deal

MT Newswires Live
·
Mar 25

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results

GlobeNewswire
·
Mar 25

Martin Shkreli, AOC Agree Kalshi Has A Problem

Benzinga_recent_news
·
Mar 25

Dow Jones Slips as Iran ‘Unlikely’ to Agree to U.S. Demands

TIPRANKS
·
Mar 24

VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs

GlobeNewswire
·
Mar 24

Press Release: Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal

Dow Jones
·
Mar 24

Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC

prnewswire
·
Mar 24

Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103

TIPRANKS
·
Mar 24

Agree Realty Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 23

Truist Raises Price Target on Agree Realty to $82 From $79, Keeps Buy Rating

MT Newswires Live
·
Mar 23

Agree Realty price target raised to $82 from $79 at Truist

TIPRANKS
·
Mar 23